1. Home
  2. DLHC vs HRTX Comparison

DLHC vs HRTX Comparison

Compare DLHC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DLH Holdings Corp.

DLHC

DLH Holdings Corp.

HOLD

Current Price

$3.95

Market Cap

58.0M

ML Signal

HOLD

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

HOLD

Current Price

$0.37

Market Cap

61.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLHC
HRTX
Founded
1969
1983
Country
United States
United States
Employees
2300
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.0M
61.2M
IPO Year
2012
2007

Fundamental Metrics

Financial Performance
Metric
DLHC
HRTX
Price
$3.95
$0.37
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
10.6K
★ 2.4M
Earning Date
12-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
$41,923,000.00
★ $154,904,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
2.57
★ 7.36
52 Week Low
$3.38
$0.26
52 Week High
$8.09
$1.58

Technical Indicators

Market Signals
Indicator
DLHC
HRTX
Relative Strength Index (RSI) 46.53 50.42
Support Level $3.61 $0.29
Resistance Level $4.23 $0.46
Average True Range (ATR) 0.16 0.04
MACD 0.02 0.00
Stochastic Oscillator 50.68 41.94

Price Performance

Historical Comparison
DLHC
HRTX

About DLHC DLH Holdings Corp.

DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: